[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Istanbul Physical Medicine Rehabilitation Training and Research Hospital\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":471},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,19,0,[8,43,77,99,117,134,161,190,215,246,269,288,315,331,350,374,401,429,452],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":26,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100642638","radiographic-cortical-thickness-of-the-humerus-in-detecting-post-stroke-regional-bone-loss-100642638",false,"NCT07651306","Radiographic Cortical Thickness of the Humerus in Detecting Post-Stroke Regional Bone Loss","Inclusion Criteria:\n\n* Patients aged 18 years and older.\n* A documented history of a single unilateral stroke that occurred at least 6 months prior to evaluation.\n* Presence of clinical hemiparesis.\n* Availability of concurrent standard anteroposterior (AP) shoulder radiographs taken within 6 months post-stroke alongside systemic DXA measurements.\n\nExclusion Criteria:\n\n* History of surgical intervention in either shoulder. History of a proximal humerus fracture.\n* Co-existing metabolic bone diseases, such as primary hyperparathyroidism or osteomalacia.\n* History of malignancy.\n* Documented history of corticosteroid use.\n* Imaging artifacts that compromise the accuracy of DXA measurements.\n* History of a secondary stroke.","ALL","18 Years",{"count":18,"type":19},65,"ESTIMATED","OBSERVATIONAL","Post-stroke immobilization and reduced weight-bearing frequently lead to significant regional bone mineral density loss and asymmetry, particularly in the paretic upper extremity, which increases fracture risks. While Dual-Energy X-ray Absorptiometry (DXA) is the gold standard for evaluating systemic bone loss, it primarily focuses on axial or lower extremity sites and lacks universal accessibility. Since routine shoulder radiographs offer an opportunistic screening tool to evaluate regional bone quality without additional radiation , this study aims to compare proximal humerus cortical bone thickness between the paretic and non-paretic sides in stroke patients and assess its correlation with systemic DXA values to determine its clinical utility.\n\nThis cross-sectional, observational study involves a retrospective data analysis of patients aged 18 and older who experienced a single unilateral stroke at least 6 months prior and present with clinical hemiparesis. Eligible participants must have concurrent standard anteroposterior shoulder radiographs and DXA measurements available from their routine clinical follow-ups. Patient demographic data, stroke characteristics, Brunnstrom stages, and systemic DXA measurements (femoral neck and lumbar spine T-scores and bone mineral density values) are systematically recorded for analysis.\n\nCortical bone thickness measurements are performed using ImageJ software on standard radiographs at points 10 cm and 12 cm distal to the highest point of the humerus. To ensure reliability, measurements for both the paretic and non-paretic sides are conducted independently by two researchers who are completely blinded to the DXA results. Statistical analyses, including paired t-tests or Wilcoxon tests and Pearson or Spearman correlations, will be used to compare the sides and evaluate the relationship between radiographic cortical thickness and systemic bone density.",[23,24,25],"Hemiparesis After Stroke","Dual Energy X-ray Absorptiometry","Osteoporosis",[27,28,25,29],"Stroke","Cortical Bone Thickness","Radiography","RECRUITING","2026-06-12",{"date":33,"type":34},"2026-06-16","ACTUAL",{"date":36,"type":34},"2026-02-22",{"date":38,"type":19},"2026-07-01",{"name":40,"class":41},"Istanbul Physical Medicine Rehabilitation Training and Research Hospital","OTHER_GOV",1,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":51,"sex":15,"minAge":52,"maxAge":53,"enrollmentInfo":54,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":56,"conditions":57,"keywords":59,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":42},"100626461","bone-myoregulation-reflex-and-postural-control-in-vitamin-d-deficiency-100626461","NCT07435935","Bone Myoregulation Reflex and Postural Control in Vitamin D Deficiency","Investigation of Postural Stability and Load-Sensitive Neuromuscular Control Mechanisms in Vitamin D Deficiency","BMR-VITD","Inclusion Criteria:\n\n* Age 20 to 40 years.\n* Ability to provide written informed consent.\n* Vitamin D deficiency group: serum 25-hydroxyvitamin D level \\\u003C10 ng\u002FmL measured within the last 3 months (routine clinical testing).\n* Healthy control group: normal vitamin D status based on routine clinical testing within the last 3 months.\n* No use of vitamin D or calcium supplementation within the last 3 months.\n\nExclusion Criteria:\n\n* Known metabolic bone disease other than vitamin D deficiency.\n* Neurological disorder (central or peripheral) or neuromuscular disease.\n* History of lower-limb surgery, fracture, or prosthesis affecting standing balance.\n* Vestibular disorder.\n* BMI \\>30 kg\u002Fm2.\n* Active malignancy.\n* Severe psychiatric disorder.\n* Skin condition preventing placement of surface EMG electrodes.",true,"20 Years","40 Years",{"count":55,"type":19},24,"This observational study aims to investigate the relationship between vitamin D deficiency, postural stability, and neuromuscular control mechanisms in adults. The study will compare individuals with vitamin D deficiency and healthy controls.\n\nParticipants will undergo a single-session evaluation including surface electromyography and postural stability assessments during standing tasks under different loading and vibration conditions. No invasive procedures, medications, or blood sampling will be performed. Previously obtained routine laboratory results will be used for vitamin D status.\n\nThe study is designed to improve understanding of neuromuscular responses associated with vitamin D deficiency and to contribute to future rehabilitation strategies.",[58],"Vitamin D Deficiency",[58,60,61,62,63,64,65,66,67,68],"Postural Stability","Balance Control","Neuromuscular Control","Surface Electromyography","Reflex Modulation","Bone Myoregulation Reflex","Standing Balance","Rehabilitation Research","Postural Sway","2026-05-22",{"date":71,"type":34},"2026-05-27",{"date":73,"type":34},"2026-03-05",{"date":75,"type":19},"2026-07-05",{"name":40,"class":41},{"id":78,"slug":79,"hasResults":11,"nctId":80,"briefTitle":81,"officialTitle":82,"acronym":4,"eligibilityCriteria":83,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":84,"enrollmentInfo":85,"targetDuration":87,"studyType":20,"phases":4,"briefSummary":88,"conditions":89,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":42},"100635158","caregiver-burden-in-caregivers-of-patients-with-multiple-sclerosis-100635158","NCT07549048","Caregiver Burden in Caregivers of Patients With Multiple Sclerosis","The Relationship Between Mood, Insomnia Severity, and Caregiver Burden in Caregivers of Patients With Multiple Sclerosis","Inclusion Criteria:\n\n* Age 18-80 years\n* Clinically diagnosed with multiple sclerosis by a neurologist\n* Being followed in the physical therapy and rehabilitation clinics during the study period\n* Having a primary or regular caregiver (family member)\n* Both patient and caregiver able to read and understand Turkish and complete questionnaires\n* Willing to participate and provide written informed consent\n\nExclusion Criteria:\n\n* Severe cognitive impairment or communication problems preventing questionnaire completion\n* Acute relapse or hospitalization due to exacerbation within the last month\n* Severe comorbid neurological, psychiatric, or systemic disease affecting assessments\n* Caregiver \\\u003C18 years old or not providing regular care\n* Paid professional caregiver\n* Caregiver with severe psychiatric, neurological, or primary sleep disorder\n* Refusal to participate","80 Years",{"count":86,"type":19},50,"1 Day","Individuals aged 18-80 years who have been clinically diagnosed with multiple sclerosis and their caregivers will be included in the study.\n\nDemographic data of the patients, including age, height, weight, and comorbidities, will be recorded. Disease-specific characteristics such as disease duration, presence of incontinence, ambulation status, and presence and severity of pain will be assessed. Functional status of the patients will be evaluated using the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Impact Scale (MSIS). Symptoms related to depression and anxiety in patients will be assessed using the Hospital Anxiety and Depression Scale (HADS).\n\nSubsequently, caregivers of the patients will be evaluated. The severity of insomnia will be assessed using the Insomnia Severity Index (ISI). Symptoms related to anxiety and depression will be evaluated using the Hospital Anxiety and Depression Scale (HADS). Caregiver burden will be assessed using the Zarit Caregiver Burden Scale.",[90],"Multiple Sclerosis","2026-04-18",{"date":93,"type":34},"2026-04-23",{"date":95,"type":19},"2026-04-20",{"date":97,"type":19},"2026-05-20",{"name":40,"class":41},{"id":100,"slug":101,"hasResults":11,"nctId":102,"briefTitle":103,"officialTitle":104,"acronym":4,"eligibilityCriteria":105,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":106,"enrollmentInfo":107,"targetDuration":87,"studyType":20,"phases":4,"briefSummary":109,"conditions":110,"keywords":4,"overallStatus":112,"whyStopped":4,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":113,"startDateStruct":114,"completionDateStruct":115,"leadSponsor":116,"locationsCount":42},"100635161","motor-imagery-reaction-time-in-individuals-with-paraplegic-spinal-cord-injury-100635161","NCT07549087","Motor Imagery Reaction Time in Individuals With Paraplegic Spinal Cord Injury","Upper and Lower Extremity Motor Imagery Reaction Time in Individuals With Paraplegic Spinal Cord Injury: A Comparative Study With Healthy Controls","Inclusion Criteria:\n\n* Aged between 18 and 65 years\n* Clinically diagnosed with spinal cord injury\n* Presence of paraplegia\n* Injury duration of at least 3 months\n* Medically stable condition\n* Ability to understand and follow study instructions\n* Ability to complete the computer-based left\u002Fright judgment task\n* Willingness to participate and provide written informed consent\n* For the healthy control group: age- and sex-compatible individuals without a history of neurological or major musculoskeletal disease, willing to participate and provide written informed consent\n\nExclusion Criteria:\n\n* Tetraplegia\n* History of other neurological disorders that may affect motor imagery performance\n* Severe cognitive impairment or communication problems preventing proper participation\n* Severe visual impairment uncorrected by glasses or lenses\n* Upper or lower extremity musculoskeletal disorders, deformities, or recent injuries that may affect task performance\n* Severe psychiatric disorder\n* Uncontrolled pain or acute medical condition at the time of assessment\n* Current participation in another interventional clinical study","65 Years",{"count":108,"type":19},128,"Individuals aged 18-65 years who have been clinically diagnosed with spinal cord injury and have developed paraplegia will be included in the study. Demographic and clinical data of the participants, including age, sex, height, weight, etiology of injury, level of injury, duration of injury, and comorbidities, will be recorded. In addition, disease-specific characteristics such as ambulation status, wheelchair use, presence of incontinence, and presence and severity of pain will be assessed. For the healthy control group, demographic data including age, sex, height, weight, and comorbidities will be recorded.\n\nMotor imagery performance of the participants will be evaluated using a computer-based left\u002Fright judgment task. In this context, both upper extremity (hand) and lower extremity (foot) images will be used to record reaction time (motor imagery reaction time) and accuracy rate. All tests will be performed under standardized conditions, in a seated position, and using the same device.",[111],"Spinal Cord Injuries","NOT_YET_RECRUITING",{"date":93,"type":34},{"date":95,"type":19},{"date":97,"type":19},{"name":40,"class":41},{"id":118,"slug":119,"hasResults":11,"nctId":120,"briefTitle":121,"officialTitle":122,"acronym":4,"eligibilityCriteria":123,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":106,"enrollmentInfo":124,"targetDuration":87,"studyType":20,"phases":4,"briefSummary":126,"conditions":127,"keywords":4,"overallStatus":112,"whyStopped":4,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":128,"startDateStruct":130,"completionDateStruct":131,"leadSponsor":133,"locationsCount":4},"100635171","kinesiophobia-fear-of-falling-functional-independence-and-psychological-status-in-spinal-cord-injury-100635171","NCT07549217","Kinesiophobia, Fear of Falling, Functional Independence, and Psychological Status in Spinal Cord Injury","The Relationship Between Kinesiophobia and Fear of Falling, Functional Independence, and Psychological Status in Individuals With Paraplegic Spinal Cord Injury: A Cross-Sectional Study","Inclusion Criteria:\n\n* Aged between 18 and 65 years\n* Clinically diagnosed with spinal cord injury\n* Presence of paraplegia\n* Injury duration of at least 3 months (to exclude acute phase effects)\n* Medically stable condition\n* Ability to understand and respond to questionnaires\n* Willingness to participate and provide written informed consent\n\nExclusion Criteria:\n\n* Tetraplegia or other neurological conditions affecting motor function\n* Severe cognitive impairment or psychiatric disorders that may interfere with assessments\n* Presence of active infection, malignancy, or severe systemic disease\n* Severe visual or hearing impairment preventing participation in assessments\n* Current participation in another interventional clinical study\n* Recent surgery or acute medical condition within the last 3 months\n* Incomplete clinical data or inability to complete questionnaires",{"count":125,"type":19},70,"Individuals aged 18-65 years who have been clinically diagnosed with spinal cord injury and have developed paraplegia will be included in the study. Demographic and clinical data of the participants, including age, sex, height, weight, etiology of injury, level of injury, duration of injury, and comorbidities, will be recorded. In addition, disease-specific characteristics such as ambulation status, wheelchair use, presence of incontinence, and presence and severity of pain will be assessed.\n\nKinesiophobia levels of the patients will be evaluated using the Tampa Scale for Kinesiophobia (TSK). Functional independence will be assessed using the Spinal Cord Independence Measure-III Self-Report (SCIM-III SR). Fall-related concerns will be evaluated using the Spinal Cord Injury-Falls Concern Scale (SCI-FCS). Pain severity will be assessed using the Visual Analog Scale (VAS), and the presence of neuropathic pain will be evaluated using the DN4 Neuropathic Pain Questionnaire.\n\nSymptoms related to anxiety and depression will be assessed using the Hospital Anxiety and Depression Scale (HADS). All assessments will be conducted through face-to-face interviews. The collected data will be analyzed to investigate the relationship between kinesiophobia and functional independence, fear of falling, pain, and psychological status in individuals with paraplegic spinal cord injury. Validated Turkish versions of all scales used in the study will be employed.",[111],{"date":129,"type":34},"2026-04-24",{"date":97,"type":19},{"date":132,"type":19},"2026-06-20",{"name":40,"class":41},{"id":135,"slug":136,"hasResults":11,"nctId":137,"briefTitle":138,"officialTitle":139,"acronym":4,"eligibilityCriteria":140,"healthyVolunteers":51,"sex":15,"minAge":106,"maxAge":4,"enrollmentInfo":141,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":143,"conditions":144,"keywords":146,"overallStatus":112,"whyStopped":4,"lastUpdateSubmitDate":154,"lastUpdatePostDateStruct":155,"startDateStruct":156,"completionDateStruct":158,"leadSponsor":160,"locationsCount":42},"100624842","muscle-strength-asymmetry-in-sarkopenic-and-non-sarcopenic-older-adults-100624842","NCT07414888","Muscle Strength Asymmetry In Sarkopenic And Non-sarcopenic Older Adults","Comparison of Dominant and Non-Dominant Side Muscle Strength Asymmetry in Sarcopenic and Non-Sarcopenic Older Adults","Inclusion Criteria:\n\n* Age 65 years or older\n* Ability to walk independently or with minimal assistance\n* Ability to understand and follow simple instructions\n* Willingness and ability to provide written informed consent\n* Availability of muscle strength measurements (handgrip, biceps, and quadriceps)\n\nExclusion Criteria:\n\n* Lack of cooperation, moderate to severe dementia (e.g., MMSE \\\u003C24) or conditions impeding cooperation.\n* Those with severe cardiovascular disease\n* Those with pacemakers\n* Surgical\u002Ffracture\u002Facute pain in the measured extremities within the last 6 months.\n* Neurological and muscular disease affecting the upper or lower extremity (acute stroke, severe peripheral neuropathy, etc.)\n* Active systemic disease attack significantly affecting the measurement.",{"count":142,"type":19},140,"The purpose of this observational study is to examine whether differences in muscle strength between the dominant and non-dominant sides of the body are associated with sarcopenia in older adults. The study will include adults aged 65 years and older with and without sarcopenia. Muscle strength will be measured on both sides of the body using handgrip strength as well as strength measurements of the biceps (upper arm muscle) and quadriceps (thigh muscle). The difference in strength between the dominant and non-dominant sides will be calculated and compared between participants with sarcopenia and those without sarcopenia.\n\nThe main question it aims to answers are:\n\n* Do older adults with sarcopenia have larger differences in muscle strength between the two sides of the body compared with those without sarcopenia?\n* Can differences in arm and leg muscle strength help identify older adults who may be at higher risk of sarcopenia?",[145],"Sarcopenia in Elderly",[147,148,149,150,151,152,153],"sarcopenia","Muscle Strength Asymmetry","Handgrip","Quadriceps","Biceps","Dominant","Non dominant","2026-03-03",{"date":73,"type":34},{"date":157,"type":19},"2026-02-12",{"date":159,"type":19},"2026-03-12",{"name":40,"class":41},{"id":162,"slug":163,"hasResults":11,"nctId":164,"briefTitle":165,"officialTitle":166,"acronym":4,"eligibilityCriteria":167,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":168,"targetDuration":4,"studyType":170,"phases":171,"briefSummary":173,"conditions":174,"keywords":176,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":183,"lastUpdatePostDateStruct":184,"startDateStruct":186,"completionDateStruct":188,"leadSponsor":189,"locationsCount":42},"100615942","the-effect-of-virtual-reality-therapy-on-upper-extremity-functions-in-subacute-stroke-patients-receiving-rehabilitation-100615942","NCT07299162","The Effect of Virtual Reality Therapy on Upper Extremity Functions in Subacute Stroke Patients Receiving Rehabilitation","The Effect of Virtual Reality Therapy on Upper Extremity Functions in Subacute Stroke Patients Receiving Conventional Rehabilitation and Action Observation Therapy: A Randomized Controlled Single-Blind Study","Inclusion Criteria:\n\n* Patients over the age of 18\n* Patients in the subacute phase of stroke (between 6 weeks and 6 months post-stroke)\n* Patients with a first-ever stroke\n* Brunnstrom stage 3 or above for both upper extremity and hand\n* Mini-Mental State Examination (MMSE) score \\>=20\n\nNo major medical condition that would prevent participation in the treatment\n\nExclusion Criteria:\n\n* Presence of pain in the paretic shoulder severe enough to prevent exercise\n* History of bilateral stroke\n* Patients with global aphasia and\u002For cognitive impairment that significantly affects treatment compliance\n* Patients with severe visual impairment\n* Presence of unilateral spatial neglect\n* Inability to maintain sitting balance\n* Modified Ashworth Scale \\> 4 in the hemiplegic arm",{"count":169,"type":19},38,"INTERVENTIONAL",[172],"NA","Stroke ranks second among the leading causes of death worldwide and third among the causes of disability. In stroke patients, motor impairment typically affects facial movements and the upper and lower extremities unilaterally. Upper extremity involvement, in particular, negatively impacts patients' activities of daily living, such as eating and dressing. Various rehabilitation methods are used to improve the function of the paretic upper extremity in stroke patients. Action Observation Therapy and Virtual Reality are among the rehabilitation approaches currently used to support upper extremity rehabilitation.\n\nIn our study, patients will be randomly divided into two groups: one group will receive conventional rehabilitation and Action Observation Therapy, while the other group will additionally receive Virtual Reality therapy. This study aims to investigate the contribution of Virtual Reality therapy, when added to conventional rehabilitation and Action Observation Therapy, to the recovery of the paretic upper extremity in patients with subacute stroke.",[27,175],"Hemiplegia and\u002For Hemiparesis Following Stroke",[177,178,179,180,181,182],"Virtual reality","action observation therapy","hemiplegia","hemiparesis","stroke","upper extremity","2026-01-26",{"date":185,"type":34},"2026-01-28",{"date":187,"type":34},"2025-08-15",{"date":95,"type":19},{"name":40,"class":41},{"id":191,"slug":192,"hasResults":11,"nctId":193,"briefTitle":194,"officialTitle":195,"acronym":4,"eligibilityCriteria":196,"healthyVolunteers":11,"sex":15,"minAge":53,"maxAge":197,"enrollmentInfo":198,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":200,"conditions":201,"keywords":203,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":208,"lastUpdatePostDateStruct":209,"startDateStruct":210,"completionDateStruct":212,"leadSponsor":214,"locationsCount":42},"100621169","neuropathic-pain-in-knee-osteoarthritis-pain-severity-and-functional-status-100621169","NCT07367126","Neuropathic Pain in Knee Osteoarthritis: Pain Severity and Functional Status","Presence of Neuropathic Pain in Knee Osteoarthritis: Relationship Between Pain Severity and Functional Status","Inclusion Criteria:\n\n* Diagnosed with Knee OA according to ACR criteria.\n* Knee pain for more than 3 months.\n* Voluntary participation.\n\nExclusion Criteria:\n\n* History of surgical intervention in the affected knee.\n* History of trauma to the affected knee within the last 6 months.\n* History of intra-articular injections (e.g., corticosteroids, hyaluronic acid, PRP) or physical therapy involving the affected knee within the last 6 months.\n* Presence of severe psychiatric disorders such as severe depression, anxiety disorder, or psychosis.\n* Diagnosis of central nervous system diseases, including Parkinson's disease or multiple sclerosis.\n* Diagnosis of inflammatory arthritis, such as Rheumatoid Arthritis or Ankylosing Spondylitis.\n* Severe cognitive impairment.\n* Chronic decompensated cardiac, renal, or hepatic failure.\n* Severe psychiatric, neurological, or kognitive disorders.\n\nDecompensated cardiac, renal, or hepatic failure.","70 Years",{"count":199,"type":19},102,"Osteoarthritis (OA) is a degenerative joint disease characterized by structural changes such as cartilage loss and osteophyte formation, leading to functional limitations and disability. Pain in knee OA involves a complex pathophysiological structure including both nociceptive and neuropathic mechanisms. Identifying the neuropathic pain component is clinically significant for improving quality of life and functional recovery. This cross-sectional controlled clinical study aims to determine the prevalence of neuropathic pain in patients with knee OA and evaluate its impact on pain severity and functional status. Patients will be categorized based on the Douleur Neuropathique 4 (DN4) questionnaire and assessed using various pain and functional scales.",[202],"Knee Osteoarthristis",[204,205,206,207],"Pain Intensity","Functional Status","Neuropathic Pain","Knee Osteoarthritis","2026-01-17",{"date":183,"type":34},{"date":211,"type":34},"2025-12-20",{"date":213,"type":19},"2026-04-30",{"name":40,"class":41},{"id":216,"slug":217,"hasResults":11,"nctId":218,"briefTitle":219,"officialTitle":219,"acronym":4,"eligibilityCriteria":220,"healthyVolunteers":51,"sex":15,"minAge":16,"maxAge":221,"enrollmentInfo":222,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":224,"conditions":225,"keywords":230,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":240,"lastUpdatePostDateStruct":241,"startDateStruct":243,"completionDateStruct":244,"leadSponsor":245,"locationsCount":42},"100616683","the-ultrasonographic-evaluation-of-abdominal-accessory-respiratory-muscle-thickness-in-patients-with-parkinsons-disease-correlation-with-disease-severity-and-expiratory-respiratory-muscle-strength-100616683","NCT07308795","The Ultrasonographic Evaluation of Abdominal Accessory Respiratory Muscle Thickness in Patients With Parkinson's Disease: Correlation With Disease Severity and Expiratory Respiratory Muscle Strength","Inclusion Criteria:\n\n* Age \\> 18 years\n* Parkinson's disease diagnosis with Modified Hoehn and Yahr stages 1-2-3\n* Mini-Mental State Examination (MMSE) score \\> 23\n* Body Mass Index (BMI) \\\u003C 30\n\nExclusion Criteria:\n\n* Active smokers\n* Individuals with a diagnosis of active chest disease\n* Those with hemodynamic instability\n* Individuals with unstable vital signs\n* Parkinson's patients who cannot be controlled with medical treatment\n* Parkinson Plus syndromes","75 Years",{"count":223,"type":19},36,"Parkinson's disease is a neurodegenerative disorder characterized by both motor and non-motor symptoms. The involvement of respiratory muscles can lead to impairments in respiratory function in these patients. In this study is to evaluate the thickness of abdominal accessory respiratory muscles using ultrasonography in patients with Parkinson's disease. Additionally, the relationship between disease severity and expiratory respiratory muscle strength will be examined.\n\nThe study will include Parkinson's patients at different stages of the disease, with respiratory muscle thickness measured via ultrasonography. The collected data will then be compared with disease severity and expiratory muscle strength.",[226,227,228,229],"Parkinson Disease (PD)","Maximum Inspiratory Pressure","Maximum Expiratory Pressure","Abdominal Accessory Respiratory Muscle Thickness",[231,232,233,234,235,236,237,238,239],"abdominal muscles ultrasonography","parkinson disease","respiratory","MIP","abdominal muscles","respiratory muscles","expiratory muscle strenght","ultrasound","maximum expiratory pressure (MEP)","2025-12-29",{"date":242,"type":34},"2026-01-02",{"date":240,"type":34},{"date":95,"type":19},{"name":40,"class":41},{"id":247,"slug":248,"hasResults":11,"nctId":249,"briefTitle":250,"officialTitle":251,"acronym":4,"eligibilityCriteria":252,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":84,"enrollmentInfo":253,"targetDuration":87,"studyType":20,"phases":4,"briefSummary":255,"conditions":256,"keywords":257,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":261,"lastUpdatePostDateStruct":262,"startDateStruct":264,"completionDateStruct":266,"leadSponsor":268,"locationsCount":42},"100611503","kinesiophobia-and-balance-in-stroke-patients-100611503","NCT07241429","Kinesiophobia and Balance in Stroke Patients","Kinesiophobia, Balance Performance, Fear of Falling, and Related Factors in Stroke Patients","Inclusion Criteria:\n\n* Voluntary participation in the study\n* Male and female patients aged 18-80\n* History of ischemic or hemorrhagic stroke\n* Functional Ambulation Scale level 3 or higher\n* Standardized mini mental test ≥ 24\n* Individuals who agree to participate in the study.\n\nExclusion Criteria:\n\n* History of musculoskeletal surgery within the last year\n* Trauma, fracture, dislocation, or tumor within the last year\n* Vestibular system disorder\n* Additional neurological disease that may affect balance (Parkinson's Disease, Multiple Sclerosis, vestibular system disorder)\n* Other rheumatological or psychiatric diseases\n* Chronic decompensated cardiac, renal, or hepatic failure",{"count":254,"type":19},138,"This is a cross-sectional clinical study planned to include 138 stroke patients receiving inpatient treatment at the Istanbul Physical Therapy and Rehabilitation Training and Research Hospital.Data on kinesiophobia (Tampa Kinesiophobia Scale-17) , balance performance (Berg Balance Scale) , balance confidence (Activities-specific Balance Confidence Scale-6) , fear of falling (Falls Efficacy Scale) , pain (VAS) , and mood (HADS) will be collected. Clinical and demographic data, including Brunnstrom stages and Barthel Index, will also be recorded. The relationships between these variables will be analyzed statistically.",[27],[258,259,260,27],"Kinesiophobia","Postural Balance","Fear of Falling","2025-11-21",{"date":263,"type":34},"2025-11-28",{"date":265,"type":34},"2025-11-15",{"date":267,"type":19},"2025-12-31",{"name":40,"class":41},{"id":270,"slug":271,"hasResults":11,"nctId":272,"briefTitle":273,"officialTitle":274,"acronym":4,"eligibilityCriteria":275,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":84,"enrollmentInfo":276,"targetDuration":278,"studyType":20,"phases":4,"briefSummary":279,"conditions":280,"keywords":4,"overallStatus":112,"whyStopped":4,"lastUpdateSubmitDate":281,"lastUpdatePostDateStruct":282,"startDateStruct":283,"completionDateStruct":285,"leadSponsor":287,"locationsCount":42},"100612432","turkish-adaptation-validity-and-reliability-study-of-the-patient-experience-with-treatment-and-self-management-scale-in-stroke-100612432","NCT07253506","Turkish Adaptation, Validity, and Reliability Study of the Patient Experience With Treatment and Self-Management Scale in Stroke","Turkish Adaptation, Validity, and Reliability Study of the Patient Experience With Treatment and Self-Management Scale in Stroke Patients","Inclusion Criteria:\n\n* Clinical diagnosis of stroke (ischemic or hemorrhagic).\n* Having spent at least 1 month at home after hospital discharge (to capture post-acute home care\u002Frehabilitation burden).\n* Community-dwelling individuals aged 18-80 years.\n* Adequate Turkish reading-writing and communication ability.\n* Ability to provide informed consent.\n* In cases of mild aphasia, ability to complete the questionnaire independently or with support.\n\nExclusion Criteria:\n\n* History of subarachnoid hemorrhage.\n* Inability to communicate effectively due to severe aphasia or severe cognitive impairment.\n* Terminal illness (life expectancy \\\u003C 6 months).\n* Inability to complete the questionnaire reliably due to a psychiatric disorder.\n* Acute phase (those hospitalized or before discharge).",{"count":277,"type":19},170,"1 Week","This study will include individuals aged 18-80 years who have been clinically diagnosed with stroke and have spent at least one month at home after discharge. Sociodemographic and clinical characteristics will be recorded. Functional status will be assessed using the Modified Rankin Scale, Brunnstrom Stages, and the Modified Barthel Index. Ambulation status will be documented with the Holden Scale.\n\nThe scale will first be translated into Turkish and then back-translated into English by a bilingual expert whose native language is English. The Turkish version of the scale will be administered to patients. Two independent evaluators will apply the scale twice, one week apart.\n\nValidity will be examined by analyzing the relationship between the scale and the Stroke Impact Scale and the Treatment Burden Questionnaire",[27],"2025-11-19",{"date":263,"type":34},{"date":284,"type":19},"2025-11-20",{"date":286,"type":19},"2026-04-10",{"name":40,"class":41},{"id":289,"slug":290,"hasResults":11,"nctId":291,"briefTitle":292,"officialTitle":293,"acronym":4,"eligibilityCriteria":294,"healthyVolunteers":51,"sex":295,"minAge":16,"maxAge":106,"enrollmentInfo":296,"targetDuration":4,"studyType":170,"phases":297,"briefSummary":298,"conditions":299,"keywords":301,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":281,"lastUpdatePostDateStruct":309,"startDateStruct":310,"completionDateStruct":312,"leadSponsor":314,"locationsCount":42},"100612431","effect-of-mechanical-loading-and-bone-loss-on-motor-neuron-activity-h-reflex-relationship-100612431","NCT07253493","Effect of Mechanical Loading and Bone Loss on Motor Neuron Activity-H-Reflex Relationship","The Effect of Mechanical Loading and Bone Loss on the Relationship Between Motor Neuron Pool Activity and H-Reflex Amplitude","Inclusion Criteria:\n\n* Being in the postmenopausal period\n* For the osteoporosis group: having femoral osteoporosis (femoral neck or total femur T-score ≤ -2.5)\n* For the control group: having no osteoporosis or osteopenia (femoral neck and total femur T-scores \\> -1, and L1-L4 and L2-L4 T-scores \\> -1)\n* Being a volunteer\n\nExclusion Criteria:\n\n* Receiving osteoporosis treatment\n* Having a peripheral or central nervous system disorder (e.g., stroke, polyneuropathy, radiculopathy, entrapment neuropathy, etc.)\n* Having acquired or hereditary muscle diseases (myopathies)\n* Having active painful lower extremity pathologies (e.g., osteoarthritis, inflammatory joint diseases, etc.)\n* Having cardiac arrhythmias\n* Having a history of other metabolic bone diseases\n* Having skin lesions at the electrode placement sites on the lower extremities\n* Being older than 65 years","FEMALE",{"count":55,"type":19},[172],"Weight-bearing exercises (e.g., running, jumping, whole-body vibration) are widely practiced due to their beneficial effects on bone development and their role in the prevention and treatment of osteoporosis. However, the underlying neuroregulatory mechanisms responsible for these positive effects have not yet been fully understood. Two main neuromodulatory mechanisms have been proposed in the literature: (i) spinal reflexes originating from muscle spindles (stretch reflex, tonic vibration reflex), and (ii) the bone myoregulation reflex (BMR) based on load-sensitive osteocytes.\n\nIt is well established that increased voluntary contraction and the associated rise in background EMG activity, that is, motor neuron pool activity, enhance muscle spindle-based reflex responses (such as the H-reflex and tendon reflex). In contrast, it has been demonstrated that the H-reflex is suppressed during bone-loading activities such as single-leg stance, jumping, or whole-body vibration.\n\nThis study is based on two hypotheses:\n\n* As mechanical loading increases, Ia inhibitory effects intensify, leading to greater H-reflex suppression.\n* During whole-body vibration, the H-reflex is suppressed due to Ia inhibition.\n\nIf this inhibition originates from load-sensitive receptors-osteocytes-and thus from the BMR, then in osteoporosis, where osteocyte number and function are reduced, H-reflex suppression will be diminished.\n\nThe aim of this research is to test these hypotheses. Confirmation of these assumptions would suggest that reflex control during weight-bearing exercise occurs predominantly through osteocyte-mediated BMR mechanisms rather than muscle spindle-based mechanisms such as the stretch or tonic vibration reflex.",[300],"Osteoporosis Postmenopausal",[302,303,304,305,306,307,308],"H-reflex","osteoporosis","whole-body vibration","mechanical load","osteocyte","bone myoregulation reflex","background EMG activity",{"date":263,"type":34},{"date":311,"type":34},"2025-11-18",{"date":313,"type":19},"2026-04",{"name":40,"class":41},{"id":316,"slug":317,"hasResults":11,"nctId":318,"briefTitle":319,"officialTitle":320,"acronym":4,"eligibilityCriteria":321,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":84,"enrollmentInfo":322,"targetDuration":87,"studyType":20,"phases":4,"briefSummary":324,"conditions":325,"keywords":4,"overallStatus":112,"whyStopped":4,"lastUpdateSubmitDate":281,"lastUpdatePostDateStruct":326,"startDateStruct":327,"completionDateStruct":328,"leadSponsor":330,"locationsCount":42},"100612433","the-relationship-between-mood-and-insomnia-severity-and-caregiver-burden-in-caregivers-of-stroke-100612433","NCT07253519","The Relationship Between Mood and Insomnia Severity and Caregiver Burden in Caregivers of Stroke","The Relationship Between Mood and Insomnia Severity and Caregiver Burden in Caregivers of Stroke Patients","Inclusion Criteria:\n\n* Age 18-80 years.\n* Clinical diagnosis of stroke (ischemic or hemorrhagic; first-ever or recurrent).\n* Ability of both the patient and caregiver to communicate in Turkish and participate in evaluations (mRS, Brunnstrom, Modified Barthel Index, Holden).\n* Caregiver must have been the primary caregiver for the patient for at least 1 month.\n* Willingness of both the patient and caregiver to participate in the study.\n\nExclusion Criteria:\n\n* History of subarachnoid hemorrhage.\n* Inability to communicate effectively due to severe aphasia or severe cognitive impairment.\n* Terminal illness (life expectancy \\\u003C 6 months).\n* Inability to reliably complete questionnaires due to a psychiatric disorder.",{"count":323,"type":19},100,"This study will include stroke patients aged 18-80 years and their caregivers. Demographic data such as age, height, weight, and comorbidities will be recorded, along with stroke-specific characteristics including duration of stroke, affected side, lesion location, and etiology. Patients' functional status will be assessed using the Modified Rankin Scale, Brunnstrom Stages, and the Modified Barthel Index, while ambulation status will be documented with the Holden Scale. Caregivers will complete the Insomnia Severity Index to assess the severity of sleep disturbances and the Hospital Anxiety and Depression Scale to evaluate anxiety and depressive symptoms. Caregiver burden will be measured using the Zarit Caregiver Burden Scale. The study aims to investigate the relationship between caregivers' mood, insomnia severity, and caregiver burden.",[27],{"date":263,"type":34},{"date":284,"type":19},{"date":329,"type":19},"2025-11-30",{"name":40,"class":41},{"id":332,"slug":333,"hasResults":11,"nctId":334,"briefTitle":335,"officialTitle":336,"acronym":4,"eligibilityCriteria":337,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":221,"enrollmentInfo":338,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":340,"conditions":341,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":343,"lastUpdatePostDateStruct":344,"startDateStruct":345,"completionDateStruct":347,"leadSponsor":349,"locationsCount":42},"100611419","botulinum-toxin-applications-in-hemiplegic-patients-100611419","NCT07240337","Botulinum Toxin Applications in Hemiplegic Patients","Retrospective Evaluation of Muscle Selection, Dosage, and Clinical Outcomes in Botulinum Toxin Applications in Hemiplegic Patients","Inclusion Criteria:\n\n* Aged between 18 and 75 years, clinically diagnosed with hemiplegia\n* Received botulinum toxin injection for upper and\u002For lower extremity spasticity\n* Availability of recorded data for two time points, including the Functional Independence Measure (FIM), Brunnstrom stage, Modified Ashworth Scale (MAS), Global Spasticity Index (GSI)\n* Documentation of injected muscles and total administered botulinum toxin dosage\n\nExclusion Criteria:\n\n* Missing essential data (e.g., absence of FIM, MAS, GSI, or GAS at either visit)\n* Major interventions during the follow-up period such as surgery or initiation of intrathecal baclofen pump therapy\n* Severe concomitant neurological disorders (e.g., progressive neurodegenerative diseases) that interfere with assessment",{"count":339,"type":19},34,"This retrospective study will be conducted by reviewing the medical records of hemiplegic patients who received botulinum toxin treatment between 2017 and 2020 at the Physical Medicine and Rehabilitation outpatient clinic of Istanbul Physical Medicine and Rehabilitation Training and Research Hospital. A total of 35 hemiplegic patients who underwent botulinum toxin injection and had at least two follow-up records (with a 6-month interval) will be included. Sociodemographic and clinical data, stroke-related characteristics, botulinum toxin dosage, injected muscle groups, medications, and comorbidities will be recorded. Functional assessments, including the Functional Independence Measure (FIM) and Brunnstrom stage, as well as spasticity evaluations using the Modified Ashworth Scale and the Global Spasticity Index, will be obtained from patient files.",[342],"Hemiplegia","2025-11-16",{"date":284,"type":34},{"date":346,"type":34},"2025-10-10",{"date":348,"type":19},"2025-11-10",{"name":40,"class":41},{"id":351,"slug":352,"hasResults":11,"nctId":353,"briefTitle":354,"officialTitle":355,"acronym":4,"eligibilityCriteria":356,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":357,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":359,"conditions":360,"keywords":362,"overallStatus":112,"whyStopped":4,"lastUpdateSubmitDate":367,"lastUpdatePostDateStruct":368,"startDateStruct":370,"completionDateStruct":372,"leadSponsor":373,"locationsCount":42},"100597362","pain-and-fascia-thickness-after-steroid-injection-in-plantar-fasciitis-100597362","NCT07057505","Pain and Fascia Thickness After Steroid Injection in Plantar Fasciitis","Assesment of Pain, Foot Function, and Ultrasonographic Evaluation of Plantar Fascia Thickness in Patients Treated With Local Corticosteroid Injection for Plantar Fasciitis","Inclusion Criteria:\n\n* Patients who were clinically diagnosed with plantar fasciitis and received corticosteroid injections\n\nExclusion Criteria:\n\n* Pregnancy\n* Patients who have had more than one corticosteroid injection in the last 6 months\n* Patients with systemic inflammatory diseases\n* Patients who have previously undergone surgery in the heel area\n* Patients with a history of local trauma",{"count":358,"type":19},33,"The aim of this study is to evaluate the effects of local corticosteroid injection on pain, foot function index, and plantar fascia thickness in patients clinically diagnosed with plantar fasciitis, and to determine whether local corticosteroid injection is an appropriate treatment option for plantar fasciitis. For this purpose, the study plans to assess plantar fascia thickness using ultrasonography, evaluate pain using the Visual Analog Scale (VAS), and investigate the impact on daily living activities in patients who have been clinically diagnosed with plantar fasciitis and treated with local corticosteroid injections.",[361],"Plantar Fasciitis",[363,364,365,366],"plantar fasciitis","plantar fascia thickness","ultrasonographic evaluation","injection","2025-07-15",{"date":369,"type":34},"2025-07-18",{"date":371,"type":19},"2025-08-01",{"date":211,"type":19},{"name":40,"class":41},{"id":375,"slug":376,"hasResults":11,"nctId":377,"briefTitle":378,"officialTitle":379,"acronym":4,"eligibilityCriteria":380,"healthyVolunteers":11,"sex":15,"minAge":381,"maxAge":84,"enrollmentInfo":382,"targetDuration":4,"studyType":170,"phases":383,"briefSummary":384,"conditions":385,"keywords":388,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":394,"lastUpdatePostDateStruct":395,"startDateStruct":397,"completionDateStruct":399,"leadSponsor":400,"locationsCount":42},"100592037","effect-of-kinesiology-taping-and-swallowing-exercises-on-suprahyoid-muscle-thickness-and-swallowing-function-in-stroke-patients-with-dysphagia-100592037","NCT06988215","Effect of Kinesiology Taping and Swallowing Exercises on Suprahyoid Muscle Thickness and Swallowing Function in Stroke Patients With Dysphagia","The Effects of Kinesiology Taping Combined With Swallowing Exercises on Oropharyngeal Muscle Thickness and Swallowing Function in Dysphagia Rehabilitation of Stroke Patients: An Ultrasonographic Assessment in a Single-Blind Randomized Controlled Trial","Inclusion Criteria:\n\n* Patients aged between 50 and 80 years\n* Diagnosed with stroke\n* Mini-Mental State Examination (MMSE) score greater than 22\n* Voluntary participation with written informed consent\n\nExclusion Criteria:\n\n* Open wounds or unresolved skin problems in the neck area\n* Known allergy to kinesiology tape or its components\n* Medically unstable conditions\n* Primary esophageal disorders (e.g., achalasia, upper esophageal sphincter dysfunction)","50 Years",{"count":223,"type":19},[172],"This randomized controlled single-blind study aims to investigate the effect of kinesiology taping combined with resistance exercises on suprahyoid muscle thickness and swallowing function in patients with stroke-related dysphagia. A total of 36 participants will be randomly assigned to an intervention group receiving real kinesiology taping and a control group receiving placebo taping, both combined with standardized swallowing exercises for 6 weeks. Outcome measures include ultrasonographic evaluation of oropharyngeal muscles (geniohyoid, mylohyoid, anterior digastric, and tongue muscles), swallowing function assessed by the Volume-Viscosity Swallow Test, EAT-10, T-SWAL-QOL, Dysphagia Handicap Index, FOIS, and Functional Ambulation Level. This study will contribute to determining effective rehabilitation methods for improving safe swallowing in post-stroke patients.",[27,386,387],"Dysphagia","Cerebrovascular Disorders",[389,390,391,392,393],"Kinesiology Taping","Dysphagia Rehabilitation","Suprahyoid Muscles","Ultrasound Assessment","Neurogenic Dysphagia","2025-05-26",{"date":396,"type":34},"2025-05-30",{"date":398,"type":34},"2025-03-04",{"date":346,"type":19},{"name":40,"class":41},{"id":402,"slug":403,"hasResults":11,"nctId":404,"briefTitle":405,"officialTitle":406,"acronym":4,"eligibilityCriteria":407,"healthyVolunteers":51,"sex":408,"minAge":16,"maxAge":106,"enrollmentInfo":409,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":411,"conditions":412,"keywords":417,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":421,"lastUpdatePostDateStruct":422,"startDateStruct":424,"completionDateStruct":426,"leadSponsor":428,"locationsCount":42},"100590474","ultrasound-assessment-of-neck-muscles-and-balance-in-male-patients-with-ankylosing-spondylitis-100590474","NCT06967883","Ultrasound Assessment of Neck Muscles and Balance in Male Patients With Ankylosing Spondylitis","The Relationship Between Ultrasonographic Measurements of Cervical Multifidus and Longus Colli Muscles and Balance in Male Patients With Ankylosing Spondylitis:Controlled Study","Inclusion Criteria:\n\n* Age between 18 and 65 years.\n* Diagnosed with Ankylosing Spondylitis according to the Modified New York Criteria (for patient group).\n* Cognitive ability sufficient to understand and follow test instructions.\n\nExclusion Criteria:\n\n* Orthopedic disorders affecting the spine or lower limbs.\n* Cardiovascular disorders.\n* Neurological disorders.\n* Visual or auditory impairments.\n* History of surgery involving the spine or lower limbs.\n* Psychiatric disorders.\n* Cognitive impairment.\n* Clinical signs or symptoms of cervical radiculopathy.","MALE",{"count":410,"type":19},76,"The aim of this study is to evaluate the relationship between ultrasonographic measurements of the cervical muscles and balance parameters in patients diagnosed with ankylosing spondylitis (AS)",[413,414,415,416],"Ankylosing Spondylitis","Balance Assessment","Balance","Spondylarthropathies; Spondylitis, Ankylosing",[418,419,420],"ankylosing spondylitis","balance","deep cervical muscles","2025-05-08",{"date":423,"type":34},"2025-05-13",{"date":425,"type":34},"2025-01-01",{"date":427,"type":19},"2025-10-01",{"name":40,"class":41},{"id":430,"slug":431,"hasResults":11,"nctId":432,"briefTitle":433,"officialTitle":434,"acronym":4,"eligibilityCriteria":435,"healthyVolunteers":11,"sex":15,"minAge":436,"maxAge":437,"enrollmentInfo":438,"targetDuration":436,"studyType":20,"phases":4,"briefSummary":440,"conditions":441,"keywords":442,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":444,"lastUpdatePostDateStruct":445,"startDateStruct":447,"completionDateStruct":449,"leadSponsor":451,"locationsCount":42},"100560147","turkish-validity-and-reliability-of-the-expanded-rehabilitation-complexity-scale-100560147","NCT06573359","Turkish Validity and Reliability of the Expanded Rehabilitation Complexity Scale","Turkish Validity and Reliability of the Expanded Rehabilitation Complexity Scale in Patients in the Stroke Palliative Care Unit","Inclusion Criteria:\n\nClinical diagnoses of stroke -\n\nExclusion Criteria: unstable cardiac and neurovascular disease\n\n\\-","2 Months","6 Months",{"count":439,"type":19},110,"The RCS is a tool that can assess the need for complex rehabilitation and objectively indicate that a patient may have difficulty functioning well at home or in the community if their medical needs are still high. Among rehabilitation patients, there are still patients with complex needs, even though they have maximized rehabilitation potential. Moreover, RCS can also be useful in highlighting cases of patients becoming seriously ill during the rehabilitation process due to an acute illness such as sepsis, which significantly limits treatment time. This information can be emphasized using RCS data when requesting extended or increased rehabilitation support.",[27],[443],"Rehabilitation Complexity Scale; needs assessment","2024-11-07",{"date":446,"type":34},"2024-11-08",{"date":448,"type":34},"2024-08-24",{"date":450,"type":19},"2025-01-07",{"name":40,"class":41},{"id":453,"slug":454,"hasResults":11,"nctId":455,"briefTitle":456,"officialTitle":457,"acronym":4,"eligibilityCriteria":458,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":459,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":460,"conditions":461,"keywords":4,"overallStatus":112,"whyStopped":4,"lastUpdateSubmitDate":463,"lastUpdatePostDateStruct":464,"startDateStruct":466,"completionDateStruct":468,"leadSponsor":470,"locationsCount":4},"100563371","mimic-muscle-volume-central-facial-palsy-severity-and-dysphagia-100563371","NCT06615297","Mimic Muscle Volume, Central Facial Palsy Severity and Dysphagia","Demonstration of the Relationship Between Mimic Muscle Volume and Central Facial Palsy Severity and Dysphagia","Inclusion Criteria:\n\n* Diagnosis of stroke and presence of unilateral central facial paralysis,\n* Agreeing to participate in the study,\n* Cognitive competence to understand the test instructions,\n* Presence of communication skills to respond to the test instructions.\n\nExclusion Criteria:\n\n* Presence of previous facial paralysis or a neurological disease other than stroke that will cause central paralysis,\n* bilateral involvement\n* illiteracy, refusal to participate in the study,\n* jaw joint problem,\n* surgical intervention in the facial area that will affect ultrasound measurements,\n* infected open wound.",{"count":125,"type":19},"70 stroke patients with central facial paralysis will be included and their demographic data will be questioned and facial nerve thickness, depressor labi inferior, depressor anguli oris, buccinator and risorius muscles will be evaluated.",[462,27],"Facial Paralysis, Central","2024-09-24",{"date":465,"type":34},"2024-09-26",{"date":467,"type":19},"2024-10-01",{"date":469,"type":19},"2025-04-01",{"name":40,"class":41},""]